Treatment Launches Landmark Doctor Built Digital Health App
VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions.
Today, Treatment announces the global launch of its much-anticipated Treatment Digital Health App, now available in the Apple App Store. The Treatment Digital Health App is a revolutionary symptom assessment tool, built and continually updated by a global team of doctors and engineers to provide users with highly predictive and accurate insights about their health. Powered by Treatment’s proprietary medical AI engine and their groundbreaking Global Library of Medicine (GLM), the Treatment Digital Health App provides the most advanced access to medical knowledge ever available for widespread use.
The Treatment Digital Health App’s health assessments go beyond what users might find through a typical online search, as the results are generated using up-to-date estimates of disease rates, current estimates of geographic variation, and the latest medical research. Doctors around the world currently trust Treatment’s AI software to provide information for their clinical assessments, and the same technology is used by leading medical schools to test students’ clinical skills. Now, Treatment Digital Health App users have access to the same groundbreaking technology.
“I am very proud of our committed global team of outstanding medical doctors and top-tier technical experts who have worked so hard to make possible Treatment’s landmark launch of this unique and powerful software. With severe global disruptions in healthcare caused by the current pandemic, people need simple-to-use, geographically relevant, and continually updated health information they can trust, and the Treatment Digital Health App provides that,” says John Fraser, CEO of Treatment.
At the heart of the Treatment Digital Health App sits Treatment’s innovative Global Library of Medicine (GLM) and their powerful AI engine -- together, these form an advanced, scalable medical intelligence platform providing global diagnoses and treatment protocols that can be tailored to accommodate local needs. “The probability-based symptom evaluation provided by the Treatment platform supports multiple products that can promote prevention, ensure quality, improve safety, reduce unnecessary costs, and improve decisions, all of which leads to better overall healthcare outcomes,” says Kevin Peterson, Chief Medical Officer of Treatment.
“Treatment truly captures the Zeitgeist in the COVID era of healthcare, which necessitates accuracy in healthcare decision making. The incredible feedback from beta users of our digital health app shows that they saw the unique difference with our comprehensive symptom assessment process, which is more like seeing a doctor than using other symptoms checkers. Our comprehensive health assessment has raised the bar for all other vendors in the marketplace. The launch of our mobile app for consumers is an important step toward better individual health and an important company milestone, but it’s just the tip of the iceberg when it comes to Treatment’s product release plan for 2022,” stated Dr. Paul A. Markham, Chief Strategy Officer of Treatment.
The Treatment Digital Health app is available worldwide on the Apple App Store and soon to be available in the Google Play store.
Treatment.com is a disruptive healthcare technology company harnessing the power of AI to help global citizens improve their health through personalized recommendations and insights. Based in Vancouver with a US subsidiary, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a sophisticated and scalable AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the company behind the new release of the Treatment Digital Health App. This doctor-built app is driven by an intelligent digital health assistant which will empower people to take control of their health. Doctors are encouraged to apply for NFT and blockchain rewards for contributing to Treatment’s growing compendium of medical knowledge housed in its proprietary Global Library of Medicine.
For more investor information on Treatment.com please visit https://treatment.com/investors/.
Forward Looking Statement
This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
For more information:
Investor Contact: [email protected]
- Extendicare Announces Timing of 2021 Fourth Quarter Results and Year End Results and Conference Call
- MEDIROM Healthcare Technologies Inc. Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
- Core One Labs Announces Successful Proof of Concept and Files Patent for Protection of its Recombinant Production System for Optimized Biosynthesis of Psilocybin
- Pennant to Present at the 2022 Stifel Seniors Housing and Healthcare Real Estate Conference
- Sharps Compliance Partners with PharMerica Corporation to Bring MedSafe to Long-Term Care Facilities
- LifeLabs partners with UBC on Drone Transport Initiative to support access to essential health services for BC First Nations communities